Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

11 Mar 2009 07:00

RNS Number : 6511O
Sopheon PLC
11 March 2009
 



Embargoed Release: 07:00hrs Wednesday 11 March 2009

Sopheon plc

('Sopheon')

Ciba Implements Sopheon's Accolade® Solution to Help Focus Innovation Investments on Most Promising Projects

PLM Software Supports Global Initiative Aimed at Improving Innovation Governance and Increasing Profits and Revenues from New Products

MINNEAPOLIS and LONDON - Mar. 112009 - Sopheon, the international provider of software and services for product lifecycle management (PLM), announced today that Ciba Inc. ('Ciba')leading global manufacturer of specialty chemicalsis implementing Sopheon's Accolade product portfolio and innovation process management solution. Ciba's deployment of the Sopheon system is core to a global initiative aimed at improving returns on innovation investments. The software is being used to enhance the company's capacity to govern its innovation processes and focus resources on high-value product innovation projects.  Accolade has been made available to more than 900 individuals on cross-functional teams responsible for product development at Ciba locations throughout Europe, Asia and the United States. 

Ciba's pedigree as an industry innovator began to develop more than two-and-a-half centuries ago when, in 1758, the company was founded as a trader in chemicals and dyes. In the ensuing years, Ciba has been responsible for scientific breakthroughs in areas ranging from high-performance pigments and antimicrobials, to chemical agents that keep vehicle coatings from peeling after excessive exposure to sunlight. Today the company focuses on the development and production of specialty chemicals, serving customers in more than 120 countries.

In 2006 Ciba set in motion an enterprise-wide effort called Operational Agenda. Its purpose is to strengthen the company's growth and profitability. The program is supported by six strategic pillars, including an initiative dedicated to promoting innovation.  A principal goal of that initiative is to reduce the overall number of projects in the new-product pipeline and ensure that R&D resources are focused on those opportunities that promise high business returns It includes Ciba's implementation of a comprehensive new framework for managing its innovation efforts.

   

Sopheon's Accolade solution will serve as the key software component for Ciba's management of its innovation system. The selection of Accolade was based on a mix of advantages, including the fact that it could be readily configured to Ciba's specific requirements and, once in place, was easy to use. The software's governing capabilities are expected to improve product-development efficiency and quality of execution, by prompting users to follow prescribed process steps and address the right business and technical questions at the right times to optimise the chances of success for projects in the pipeline. Project management will be enhanced by increased transparency as Accolade system managerare able to not only retrieve instant updates on the status of individual projects, but to access consolidated views that allow them to assess the cost, value and priority of projects comprising entire portfolios.

"The introduction of Sopheon's Accolade system accompanied the rejuvenation of Ciba's innovation infrastructure," said Martin Riediker, chief innovation officer for Ciba. "The solution has provided us with a state-of-the-art innovation management system. For the first time, we are able to monitor all aspects of our R&D initiatives and make truly well-informed decisions about which ones to support. As a result, we are in a position to significantly reduce the number of active projects in our development pipeline, and to back the most promising opportunities with more resources. Ultimately, Accolade will also allow us to track and assess the returns on our innovation investments.  It gives us the foundation we need to achieve profitable growth from product innovation well into the future."

Sopheon partners, Sopheon Vertriebs GmbH and Sopheon Business Applications GmbH, were responsible for the sale, implementation and support of Accolade at Ciba.

Dieter Jaeger, chief executive officer of Sopheon Vertriebs GmbH, said, "Innovation has played a critical role throughout Ciba's history. The company's current strategic initiative on innovation is a comprehensive, multi-faceted approach to innovation management. Sopheon's software has been characterised by Ciba as 'the glue that holds it all together.'  With the introduction of Accolade, Ciba is moving the oversight and management of its innovation efforts to a whole new level.

Accolade is a registered trademark of Sopheon plc

-Ends-

For further information:

Barry Mence, Chairman

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Vikki Krause

Hansard Communications

+ 44 (0) 207 245 1100

+ 44 (0) 7957 203 685

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

Paul Davies, 

Corporate Finance

Seymour Pierce

+ 44 (0) 207 107 8000

About Ciba Inc.

Ciba (SWX: CIBN) is a leading global company dedicated to producing high-value effects for its customers' products.  Its products add performance, protection, colour and strength to plastics, paper, automobiles, buildings, home and personal care products and much more. Ciba is active in more than 120 countries around the world and is committed to being a leader in its chosen markets. In 2008, the company generated sales of CHF 5.9 billion from continued operations and invested over CHF 230 million in R&D. For more information, please visit www.ciba.com.

About Sopheon

Sopheon (LSE:SPE) is an international provider of product lifecycle management software and services. Its solutions help organizations increase revenues and profits from new products by synchronizing innovation planning and execution. Sopheon's Accolade® software automates the product innovation process and provides strategic decision support for the management of product portfolios. Its Vision Strategist solution automates the roadmapping process, allowing users to visualize and forecast the future of products, markets and technologies. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Cadbury Schweppes, Corning, Electrolux, General Motors, Honeywell, Motorola, Nestle and SAB Miller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASFIFASSUSESD
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.